TY - GEN
T1 - Controlled drug release from dental obturation cements
AU - Tiago, João
AU - Serro, Ana Paula
AU - Moutinho, Maria Guilhermina
PY - 2012
Y1 - 2012
N2 - The main purpose of this work is to investigate the release of antibiotics incorporated in dental obturation cements. It constitutes a first approach to the development of a type of drug delivery system with great interest and potential, that still is practically inexistent in the market. Several antibiotics and root canal sealers (RCS) were pretested through microbiological and dissolution tests, respectively in order to select the system(s) to study. Ampicillin was chosen to be incorporated in two commercial RCS, AH Plus® and EndoREZ®. The drug release kinetics was evaluated by high performance chromatography (HPLC) as a function of drug load and film thickness, and its microbiological efficacy after release was proven. For both sealers, ampicillin release occurred in the first few hours and depends on the drug load and film thickness. The relative amount released from EndoREZ® was higher, due to its higher hydrophilicity and porosity.
AB - The main purpose of this work is to investigate the release of antibiotics incorporated in dental obturation cements. It constitutes a first approach to the development of a type of drug delivery system with great interest and potential, that still is practically inexistent in the market. Several antibiotics and root canal sealers (RCS) were pretested through microbiological and dissolution tests, respectively in order to select the system(s) to study. Ampicillin was chosen to be incorporated in two commercial RCS, AH Plus® and EndoREZ®. The drug release kinetics was evaluated by high performance chromatography (HPLC) as a function of drug load and film thickness, and its microbiological efficacy after release was proven. For both sealers, ampicillin release occurred in the first few hours and depends on the drug load and film thickness. The relative amount released from EndoREZ® was higher, due to its higher hydrophilicity and porosity.
KW - AH Plus®
KW - EndoREZ®
KW - ampicillin
KW - drug release
UR - http://www.scopus.com/inward/record.url?scp=84869418207&partnerID=8YFLogxK
U2 - 10.1109/ENBENG.2012.6331392
DO - 10.1109/ENBENG.2012.6331392
M3 - Conference contribution
AN - SCOPUS:84869418207
SN - 9781467345248
T3 - 2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012
BT - 2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012
T2 - 2012 IEEE 2nd Portuguese Meeting in Bioengineering, ENBENG 2012
Y2 - 23 February 2012 through 25 February 2012
ER -